get a key
steadybase-$ company SXTC
account_id none on file
legal_name China SXT Pharmaceuticals, Inc.
ticker SXTC
cik 1723980
domain sxtchina.com
entry_point_account_id none on file
name China SXT Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 10 executives 7 family 0
why_nownone on file
callsnone on file
filings
a non-accountable expense reimbursement in an amount equal to half percent (0.5%) of the gross proceeds of the Offering, and out-of-pocket

filing / Jul 1, 2026 / receipt

Xiaodong Pan was appointed as our Chief Financial Officer on January 31, 2022. He has served as the Finance Director of Jiangsu Suxuantang Pharmaceutical Co., Ltd., the consolidated variable interests entity of the Company in China, since March 2015.

filing / Jul 1, 2026 / receipt

Over the long term, we intend to expand our presence beyond the PRC to international markets by partnering with international pharmaceutical companies in cross-selling our products.

filing / Jul 1, 2026 / receipt

Feng Zhou | 35 | Co-Chief Executive Officer and Director

filing / Jul 1, 2026 / receipt

Simon Lim Sze Beng | 50 | Co- Chief Executive Officer

filing / Jul 1, 2026 / receipt

Xiaodong Pan | 49 | Chief Financial Officer

filing / Jul 1, 2026 / receipt

Jun Zheng | 50 | Director

filing / Jul 1, 2026 / receipt

Tong Liu | 48 | Independent Director

filing / Jul 1, 2026 / receipt

Xiaodong Ji | 57 | Independent Director

filing / Jul 1, 2026 / receipt

Yong Lip Chee | 38 | Independent Director

filing / Jul 1, 2026 / receipt

executives
Feng Zhou Co-Chief Executive Officer and Director - receipt
Jun Zheng Director - receipt
Simon Lim Sze Beng Co- Chief Executive Officer - receipt
Tong Liu Independent Director - receipt
Xiaodong Ji Independent Director - receipt
Xiaodong Pan Chief Financial Officer - receipt
Yong Lip Chee Independent Director - receipt
familynone on file
upcoming
2026-10-07 earnings call scheduled
changesnone on file
mcp_package_hint
steadybase-$